M

Marc Toth

About

Detail

CEO Heart and Vascular Center of Arizona
Tucson, Arizona, United States

Timeline


work
Job
school
Education

Résumé


Jobs verified_user 0% verified
  • Basata
    Member of the Board of Advisors
    Basata
    Dec 2024 - Current (1 year 7 months)
    Basata will enable a healthcare system in which every moment is spent on patient care. Basata is your partner in eliminating healthcare administrative backlogs. Our AI agents take care of your documents so you can invest that time in your patients. We offer powerful automation to streamline your document management and track your practice's efficiency with our analytics dashboard.
  • Nudj Health
    Advisory Board Member
    Nudj Health
    Dec 2024 - Current (1 year 7 months)
    Nudj provides a comprehensive care plan summarizing the patient's health problems, wellness goals, providers, medications and a care manager that connects patients with resources to support their overall wellbeing. Nudj has a team of case managers, nurses and specialists available to support patients in the Chronic Care Management (CCM) Program. Additionally, CCM patients are able to attend health and wellness classes offered through Nudj Academy where classes are offered weekly on the areas of nutrition, yoga, stress management, health education and exercise. An interdisciplinary team of behavioral specialists will baseline a patient's current wellness, identify health goals and target one lifestyle area (sleep, stress management, nutritio
  • FibriCheck
    Member of the Board of Advisors
    FibriCheck
    Oct 2024 - Current (1 year 9 months)
    FibriCheck is a medically certified and FDA-cleared tool to detect and monitor arrhythmias, including AF by using PPG-technology. The FibriCheck ecosystem consists of a patient-facing app, a validated AI algorithm and a portal for healthcare professionals.
  • A
    Member Board of Directors
    Anchor Balloon
    Jun 2024 - Current (2 years 1 month)
  • A
    Member Board of Directors
    Anchor Balloon
    Jun 2024 - Current (2 years 1 month)
    Novel Angioplasty Balloon with Guidewire Anchoring Technology that Enables Device Advancement: *Interventional Cardiology *Neurointervention *Interventional Radiology *Endovascular Interventions One of the key design elements of Anchor Balloon is a special thinned and collapsible segment of the inner shaft of the balloon catheter. As the balloon pressurizes, this collapsing locks the guidewire into place and thus provides therapeutics, like a stent, a stable rail to be advanced to the area of interest (Lesion).
  • Cardiovascular Associates of America  CVAUSA
    CEO Heart and Vascular Center of Arizona
    Cardiovascular Associates of America CVAUSA
    Apr 2024 - Current (2 years 3 months)
    Cardiovascular Associates of America (CVAUSA) brings together national leaders in heart and vascular care with the common mission of saving lives, reducing costs, and improving patient care through clinical innovation. At a critical moment for the cardiovascular sector, a partnership with CVAUSA provides the approach, tools, and resources to elevate patient care, lower costs, improve access and efficiency, and deliver better health outcomes to patients throughout the US. At CVAUSA, we believe the people who deliver the care are the same people who have the solutions to improve the industry around it. The practices we invest in maintain clinical and operational autonomy and continue to manage local operations while remaining highly involved
  • Siensmetrica Inc
    Co-Founder
    Siensmetrica Inc
    Apr 2024 - Current (2 years 3 months)
    Siensmetrica https://siensmetrica.com/ is a data technology company addressing critical needs in the medical, life sciences and biopharma industries with artificial intelligence. Our mission is to deliver a platform that continually organizes, scores, and rates all scientifically relevant data using an unbiased AI powered analysis. The amount of scientific research published annually is growing exponentially. This deluge of data makes it nearly impossible for the world’s scientific and medical communities to collate, organize and synthesize all the latest scientific literature relevant to their field of study. Our goal is to forge partnerships with healthcare and scientific researchers, broadening our impact and contributing to the trans
  • DEOcare
    Member Board of Directors
    DEOcare
    Jan 2024 - Current (2 years 6 months)
    DEO (Data-driven Efficiency for the Operating Room) was founded in Belgium in 2018 - with US headquarters in Ann Arbor, MI since 2022 - with the aim of improving operational excellence in the operating room (OR). DEO has developed an AI backed data and insights platform that enables a virtual simulation that duplicates the layout, procedures, team, and overall environment of each OR. This is paired with a proprietary database to simulate improvements that ultimately increase surgery volume, optimize staff workload and improve financial performance. The proprietary technology has been successfully used and validated in dozens hospitals in Europe and the US - capturing thousands of surgeries - and is now commercialized in those regions b
  • M
    Chairman of the Board of Directors
    MedAtlas
    Jun 2022 - Apr 2024 (1 year 11 months)
  • Atlas Healthcare Partners
    Chairman of the Board of Directors
    Atlas Healthcare Partners
    Jun 2022 - Apr 2024 (1 year 11 months)
  • Ambulatory Surgery Center Association ASCA
    Cardiovascular Advisory Committe
    Ambulatory Surgery Center Association ASCA
    Jan 2022 - Oct 2025 (3 years 10 months)
    ASCA’s Government Affairs Department promotes the interests of the ASC community before federal and state legislative, regulatory and executive agencies. By working with state ASC associations and industry leaders, the department is able to identify and analyze critical health policy issues concerning ASCs and acts to enhance and protect their ability to continue providing high-quality patient care.
  • Atlas Healthcare Partners
    Market President, Cardiovascular Services
    Atlas Healthcare Partners
    Dec 2019 - Apr 2024 (4 years 5 months)
    As the President of Cardiovascular Services, and Chairman of the MedAtlas CV Board of Directors, Marc led a team working to transform cardiovascular care delivery and expand patient access to high-quality cardiovascular ambulatory surgery centers (ASCs). He oversaw the development and management of both the day-to-day business and clinical operations of cardiovascular ASCs for Banner Health, Corewell Health, as well as expansion efforts with Atlas’ newest JV partner MedAxiom. Marc has 25+ years of leadership experience in the cardiovascular/cardiology marketplace, including product commercialization, physician-practice and outpatient-vascular-lab valuations, capital acquisition, and exit strategies. He also has been an M&A Advisor represen
  • A
    CEO
    ACA Cardiovascular
    Apr 2017 - Dec 2019 (2 years 9 months)
    ACA Cardiovascular is a Cardiovascular Ambulatory Surgery Center development and management company. We have over 35 year's experience in developing and managing Ambulatory Surgery Centers across the US. Our 100% focus is developing and managing Cardiovascular 'Hybrid' Ambulatory Surgery Centers. This model combines a Medicare certified Ambulatory Surgery Center and an Office Based Lab in the same center, and enables the center to access both site of service reimbursement structures.
  • VERTESS
    Healthcare Consultant
    VERTESS
    Apr 2014 - Mar 2017 (3 years)
    As a Consultant at VERTESS, I helped physician owned endovascular labs look for economic and strategic partnerships. I focused on physician practice and out patient vascular lab valuations, capital acquisition and exit strategies.
  • R
    Vice President of Sales
    Roxwood Medical Inc
    Oct 2013 - Mar 2017 (3 years 6 months)
    I was responsible for the US and International commercialization of technology used in complex Cardiology and Endovascular procedures, and help lead Roxwood to a successful sale to BTGplc International for $80M USD. I successfully built and managed a team of Direct Sales Professionals and Distributors who have launched 6 new medical device platforms to US and international Key Opinion Leaders in the Coronary and Peripheral Vascular marketplaces. I have developed and implemented sales strategies, marketing programs, national and international contracts and compensation models that have lead to 30% quarter over quarter sales growth.
  • S
    Market Development Manager
    SentreHEART Inc
    Jan 2012 - Dec 2013 (2 years)
    As a Consultant at VERTESS, I helped physician owned endovascular labs look for economic and strategic partnerships. I focused on physician practice and out patient vascular lab valuations, capital acquisition and exit strategies.
  • H
    Strategic Advisor
    HealthLoop Inc
    Jan 2011 - Dec 2013 (3 years)
    I helped lead a team that developed a beta trial at Henry Ford Hospital’s Cardiology Department with HealthLoop’s patient engagement solution. This SaaS platform coordinates care to lower costs, improve outcomes, and drive a 5-star patient experience by collecting actionable data through engaging guidance and reassuring interactions to provide timely intervention with the patients that need it most.
Education verified_user 0% verified
  • University of Michigan  Stephen M Ross School of Business
    BBA, Business
    University of Michigan Stephen M Ross School of Business
  • University of Michigan Business School
    BBA, Business
    University of Michigan Business School
This is a community-created genome.